Pangaea Ventures joins Vestaron's $18 mln Series D round
Vestaron Corp, a U.S. biological insecticide company, has secured US$18 million in a Series D financing. The round was backed by existing investors, including Pangaea Ventures, a Canadian venture capital firm. Based in Kalamazoo, Michigan, Vestaron develops safe and effective bio-insecticides derived from naturally occurring peptides for agricultural and other applications. The company plans to use the funds raised to expand its research and development activity. Pangaea General Partner Keith Gillard is Vestaron's chairman.
4 August 2016•3 mins read
